Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
FGF23 Decreases Renal NaPi-2a and NaPi-2c Expression and Induces Hypophosphatemia In Vivo Predominantly Via FGF Receptor 1
American Journal of Physiology: Renal Physiology, 06/11/09
Gattineni J et al. - The data show that FGFR1 is the predominant receptor for the hypophosphatemic action of FGF23 in vivo with FGFR4 likely playing a minor role.
Related Articles
Identification of a novel dentin matrix protein-1 (DMP-1) mutation and dental anomalies in a kindred with autosomal recessive hypophosphatemia
Bone, 10/21/09
Relevance Score: 82%
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas
Cancer Chemotherapy and Pharmacology, 11/12/09
Relevance Score: 77%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Transcriptional networks controlling chondrocyte proliferation and differentiation during endochondral ossification
Pediatric Nephrology, 12/07/09
Conditionally immortalized human podocyte cell lines established from urine
American Journal of Physiology: Renal Physiology, 12/04/09
Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues
Journal of Cancer Research & Clinical Oncology, 12/04/09
Article Search
Sponsor


See Latest Articles


